0001646331-17-000004.txt : 20170905 0001646331-17-000004.hdr.sgml : 20170904 20170901173529 ACCESSION NUMBER: 0001646331-17-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170901 EFFECTIVENESS DATE: 20170905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Constance Therapeutics, Inc. CENTRAL INDEX KEY: 0001646331 IRS NUMBER: 475135880 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293998 FILM NUMBER: 171067018 BUSINESS ADDRESS: STREET 1: 981 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 510-455-1473 MAIL ADDRESS: STREET 1: 981 HOWARD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0708 D LIVE 0001646331 Constance Therapeutics, Inc. 981 HOWARD STREET SAN FRANCISCO CA CALIFORNIA 94103 510-455-1473 DELAWARE None None Corporation true 2015 Constance Finley 981 Howard Street San Francisco CA CALIFORNIA 94103 Executive Officer Director Other Decline to Disclose 06c false 2017-06-26 false true false 25000 None None None None Na NA Na CA CALIFORNIA NA CA CALIFORNIA FL FLORIDA IL ILLINOIS true 3600000 499980 3100020 false 4 0 0 50000 true false Constance Therapeutics, Inc. Constance Finley Constance Finley CEO & Founder 2017-08-31